Search Results - M. Nechaeva
- Showing 1 - 5 results of 5
-
1
296P Tumour mutational burden and clinical outcomes with first-line atezolizumab and nab-paclitaxel in triple-negative breast cancer: Exploratory analysis of the phase III IMpassio... by Leisha A. Emens, Luciana Molinero, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiß, Véronique Dièras, Hiroji Iwata, Carlos H. Barrios, M. Nechaeva, EP Winer, CL Chang, Jane Yuet Ching Hui, Peter Schmid, Sherene Loi
Published 2020Artigo -
2
Atezolizumab and <i>nab</i>-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study by Leisha A. Emens, Luciana Molinero, Sherene Loi, Hope S. Rugo, Andreas Schneeweiß, Véronique Dièras, Hiroji Iwata, Carlos H. Barrios, M. Nechaeva, Anh Nguyen‐Duc, Jane Yuet Ching Hui, Amreen Husain, Eric P. Winer, Sylvia Adams, Peter Schmid
Published 2021Artigo -
3
O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study by Rebecca Kristeleit, Alla Lisyanskaya, А. А. Феденко, Mikhail Dvorkin, Andréia Cristina de Melo, Y. Shparyk, Irina Rakhmatullina, Igor Bondarenko, Nicoletta Colombo, Valentyn Svintsitskiy, Luciano Biela, M. Nechaeva, Francesco Raspagliesi, Giovanni Scambia, David Cibula, Ròbert Póka, Ana Oaknin, Tamar Safra, Beata Maćkowiak-Matejczyk, Ling Ma
Published 2021Artigo -
4
1628TiP Romiplostim for chemotherapy-induced thrombocytopenia (CIT) in solid tumors: Two phase III, international, randomized controlled trials (RCT) by H. Al-Samkari, Caglayan Geredelı, C. Arslan, I. Korantzis, G.G. Dogu, M. Nechaeva, M. Salgado Fernandez, Beatriz González Astorga, Ventseslav Yordanov, T. Ciuleanu, C. Bowers, A. Armas, F. Scotté, J.F.C. Camargo, C.G. Munoz Sanchez-Miguel, P.A. Bunn, D. Kuter, G.A. Soff
Published 2022Artigo -
5
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Stud... by Dmytro Trukhin, Elena Poddubskaya, Zoran Andrić, Tamta Makharadze, Ravi Shankar Bellala, Chaiyut Charoentum, Eduardo Patricio Yanez Ruiz, Andrea Fülöp, Irfhan Ali Hyder Ali, Kostas Syrigos, Nuran Katgı, Yamil Alonso Lopez Chuken, Ilieva Rumyana, Jasmin Reyes-Igama, Rita de Cássia Costamilan, Ana Del Campo García, Amalia Florez, Alexandra Paravisini, Susana Millán, Luiz H. Araujo, Carla Maria de Oliveira Ferreira, Hélio Pinczowski, Maria Marcela Fernandes Monteiro, Assen Dudov, Janeta Syrova, Francisco Javier Orlandi Jorquera, Carlos Eduardo Gallardo Arenada, Christian Lorenzo Caglevic Medina, Davit Giorgadze, Nino Mchedlidze, Vladimer Kuchava, Tamar Melkadze, Amiran Matitashvili, Nana Chikhladze, E Samantas, Theodoros Kontakiotis, Beatrix Bálint, Balazs Medgyasszay, Eszter Csánky, Shailesh Bondarde, Lovenish Goyal, Ajay Sharma, Baijumon Balan, Prabrajya Narayan Mohapatra, Kaushalkumar Babubhai Patel, Sachin Sharadchandra Hingmire, Mithun Satish Shah, Kartikeya Jain, Ashish Agrawal, Prashant Kumbhaj, Asis Mukhopadhyay, Paul Khoueiry, Suhana Yusak, Yong Kek Pang, V. Pei Jye, Prathepamalar Yehgambaram, Fuad Ismail, Gokula Kumar Appalanaido, Feliciano Barrón, Ma. Noemi Uy, Felycette Gay Martinez-Lapus, Maria Belen Tamayo, Jennifer Sandoval-Tan, Jamela Anne Osorio Sanchez, Christina G. Galvez, Josephine Contreras-Tolentino, Evgeny Ledin, Daniil Stroyakovskiy, I. V. Kudryavtsev, Vladimir Vladimirov, Evgeniy Gotovkin, М. В. Шомова, Guzel Mukhametshina, Igor Lifirenko, Nina Karaseva, M. Nechaeva, Anna V. Tarasova, Alexander Luft, Lyudmila Kuzina, Marina Petrović, Milan Rančić, Borjan Zaric, Manoch Buranachokphaisan, Sarayut Lucien Geater, Ekkapong Tharavichitkul, Mahmut Gümüş, Igor Bondarenko, Yaroslav Shparyk, Serhii Shevnia, Iryna Lytvyn, Oleksii Kolesnik, Yevhen Hotko, Ivan Sinielnikov, Hryhoriy Adamchuk, Grygorii Ursol, О. І. Іващук, Yuriy Ostapenko, Tetiana Popovska
Published 2021Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Oncology
Chemotherapy
Cancer
Environmental health
Population
Randomized controlled trial
Atezolizumab
Biochemistry
Biology
Breast cancer
Carboplatin
Cisplatin
Clinical endpoint
Immunotherapy
Metastatic breast cancer
Pembrolizumab
Triple-negative breast cancer
BRCA mutation
Bevacizumab
Biomarker
Biosimilar
CD8
Cancer research
Chemistry
Confidence interval
Gastroenterology
Gemcitabine
Gene